ODDB.org: Open Drug Database

Mepha Pharma AG - Olmesartan-Amlodipin-HCT-Mepha 40 mg/10 mg/25 mg, Lactab

Swissmedic Registration	67602	Sequence	05
Product name	Olmesartan-Amlodipin-HCT-Mepha 40 mg/10 mg/25 mg	Description	Lactab
ATC-Classification	C09DX03	ATC-Description	Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide
Introduction of Sequence	11.08.2020

Composition

Filmtablette: olmesartanum medoxomilum 40 mg, amlodipinum 10 mg ut amlodipini besilas 13.86 mg, hydrochlorothiazidum 25 mg, cellulosum microcristallinum, lactosum monohydricum 38 mg, crospovidonum, povidonum K 30, carboxymethylamylum natricum A corresp. natrium 0.42 mg, silica colloidalis anhydrica, magnesii stearas, Überzug: poly(alcohol vinylicus), E 171, E 172 (rubrum), macrogolum 4000, talcum, pro compresso obducto.

Packungsbestandteile

Galenic Form

Coated tablets

Active Agent	Dose	additional_information
Amlodipine	10 mg
Hydrochlorothiazide	25 mg
Olmesartanum Medoxomilum	40 mg	Filmtablette

BAG: Active Agent	Dose
Amlodipine	10 mg
Hydrochlorothiazide	25 mg
Olmesartan Medoxomil	40 mg

Inactive agents	Dose	additional_information
(Rubrum)
Carboxymethylamylum Natricum A
Cellulosum Microcristallinum
Crospovidonum
E 171		color.
E 172		color.
Lactose Monohydrate	38 mg
Macrogol	4000
Magnesii Stearas
Poly(Alcohol Vinylicus)		Überzug
Povidonum K	30
Pro Compresso Obducto
Silica Colloidalis Anhydrica
Talcum

Package number	Package Size	EFP	CP	Category	SL	Out of trade (MedRef)
009	28	20.53	40.00	B	SL	Yes
010	98	62.18	87.85	B	SL	Yes

2024	©ywesee GmbH